Literature DB >> 17644209

High insulin levels impair intracellular receptor trafficking in human cultured myoblasts.

Anna Bertacca1, Annamaria Ciccarone, Paolo Cecchetti, Barbara Vianello, Incoronata Laurenza, Stefano Del Prato, Luca Benzi.   

Abstract

Chronic hyperinsulinemia is both a marker and a cause for insulin resistance. This study analyzes the effect of long-term exposure to high insulin levels on insulin-insulin receptor metabolism in human myoblasts. Cells were grown in the presence of low (107 pM, SkMC-L) or high (1430 pM, SkMC-H) insulin concentrations. Insulin receptor (IR) phosphorylation, IR internalization, dissociation and recycling, as well as insulin degradation have been investigated. Basal IR phosphorylation was higher in SkMC-H than in SkMC-L (P<0.01) but after acute insulin stimulation (10nM insulin for 10 min), IR phosphorylation increased (P<0.01) in SkMC-L, but not in SkMC-H. Chronic hyperinsulinism significantly decreased insulin-IR complex internalization (P<0.01). Nevertheless the t(1/2) value of receptor internalization was similar in both cells. Intracellular dissociation of insulin-IR complex was slightly but significantly lower in SkMC-H than in SkMC-L. Finally, SkMC-H showed a complete, but significantly delayed recycling of IR to plasma membrane (t(1/2)=20 min versus SkMC-L t(1/2)=7 min). The time course of intracellular degradation measured by HPLC, showed whenever studied, significantly (P<0.01) higher levels of intracellular intact insulin in cells exposed to high insulin concentrations. Nevertheless, the patterns of insulin degradation were over-imposable between SkMC-H and SkMC-L. In summary, continuous exposure of cultured myoblasts to high insulin levels induces subtle derangements of intracellular receptor trafficking and insulin degradation. These alterations may contribute to the insulin resistance of hyperinsulinemic states such as obesity and Type 2 Diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644209     DOI: 10.1016/j.diabres.2007.06.001

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  6 in total

1.  Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation.

Authors:  Jianwen Wei; Mathieu Ferron; Christopher J Clarke; Yusuf A Hannun; Hongfeng Jiang; William S Blaner; Gerard Karsenty
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

Review 2.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

3.  Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer.

Authors:  Sofie Björner; Ann H Rosendahl; Maria Simonsson; Andrea Markkula; Karin Jirström; Signe Borgquist; Carsten Rose; Christian Ingvar; Helena Jernström
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-28       Impact factor: 5.555

4.  Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment.

Authors:  Sofie Björner; Ann H Rosendahl; Helga Tryggvadottir; Maria Simonsson; Karin Jirström; Signe Borgquist; Carsten Rose; Christian Ingvar; Helena Jernström
Journal:  Front Endocrinol (Lausanne)       Date:  2018-06-06       Impact factor: 5.555

Review 5.  Insulin Receptor Trafficking: Consequences for Insulin Sensitivity and Diabetes.

Authors:  Yang Chen; Lili Huang; Xinzhou Qi; Chen Chen
Journal:  Int J Mol Sci       Date:  2019-10-10       Impact factor: 5.923

6.  Intermittent Fasting for Twelve Weeks Leads to Increases in Fat Mass and Hyperinsulinemia in Young Female Wistar Rats.

Authors:  Ana Cláudia Munhoz; Eloisa Aparecida Vilas-Boas; Ana Carolina Panveloski-Costa; Jaqueline Santos Moreira Leite; Camila Ferraz Lucena; Patrícia Riva; Henriette Emilio; Angelo R Carpinelli
Journal:  Nutrients       Date:  2020-04-09       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.